Medical Care
Biopharma Potency Assays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Oct 06, 24
- ID: 595077
- Pages: 113
- Figures: 187
- Views: 9
The global market for Biopharma Potency Assays was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharma Potency Assays, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharma Potency Assays by region & country, by Type, and by Application.
The Biopharma Potency Assays market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma Potency Assays.
Market Segmentation
By Company
ARL Bio Pharma
BioPharm International
Charles River Laboratories
DiscoverX
Eurofins Scientific
Intertek
Kymos
Pacific BioLabs
Pharmaron
Promega
Sartorius
SGS
ViruSure
Zelle Biotechnology
Segment by Type:
Intracellular Potency Assay
Extracellular Potency Assay
Segment by Application
Pharmaceutical
Cytology
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biopharma Potency Assays manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biopharma Potency Assays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biopharma Potency Assays in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharma Potency Assays, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharma Potency Assays by region & country, by Type, and by Application.
The Biopharma Potency Assays market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma Potency Assays.
Market Segmentation
By Company
ARL Bio Pharma
BioPharm International
Charles River Laboratories
DiscoverX
Eurofins Scientific
Intertek
Kymos
Pacific BioLabs
Pharmaron
Promega
Sartorius
SGS
ViruSure
Zelle Biotechnology
Segment by Type:
Intracellular Potency Assay
Extracellular Potency Assay
Segment by Application
Pharmaceutical
Cytology
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biopharma Potency Assays manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biopharma Potency Assays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biopharma Potency Assays in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Biopharma Potency Assays Product Introduction
1.2 Global Biopharma Potency Assays Market Size Forecast
1.3 Biopharma Potency Assays Market Trends & Drivers
1.3.1 Biopharma Potency Assays Industry Trends
1.3.2 Biopharma Potency Assays Market Drivers & Opportunity
1.3.3 Biopharma Potency Assays Market Challenges
1.3.4 Biopharma Potency Assays Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharma Potency Assays Players Revenue Ranking (2023)
2.2 Global Biopharma Potency Assays Revenue by Company (2019-2024)
2.3 Key Companies Biopharma Potency Assays Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharma Potency Assays Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharma Potency Assays
2.6 Biopharma Potency Assays Market Competitive Analysis
2.6.1 Biopharma Potency Assays Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharma Potency Assays Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Potency Assays as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Intracellular Potency Assay
3.1.2 Extracellular Potency Assay
3.2 Global Biopharma Potency Assays Sales Value by Type
3.2.1 Global Biopharma Potency Assays Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharma Potency Assays Sales Value, by Type (2019-2030)
3.2.3 Global Biopharma Potency Assays Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Cytology
4.1.3 Other
4.2 Global Biopharma Potency Assays Sales Value by Application
4.2.1 Global Biopharma Potency Assays Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharma Potency Assays Sales Value, by Application (2019-2030)
4.2.3 Global Biopharma Potency Assays Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharma Potency Assays Sales Value by Region
5.1.1 Global Biopharma Potency Assays Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharma Potency Assays Sales Value by Region (2019-2024)
5.1.3 Global Biopharma Potency Assays Sales Value by Region (2025-2030)
5.1.4 Global Biopharma Potency Assays Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharma Potency Assays Sales Value, 2019-2030
5.2.2 North America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharma Potency Assays Sales Value, 2019-2030
5.3.2 Europe Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharma Potency Assays Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharma Potency Assays Sales Value, 2019-2030
5.5.2 South America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharma Potency Assays Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharma Potency Assays Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharma Potency Assays Sales Value
6.3 United States
6.3.1 United States Biopharma Potency Assays Sales Value, 2019-2030
6.3.2 United States Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharma Potency Assays Sales Value, 2019-2030
6.4.2 Europe Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharma Potency Assays Sales Value, 2019-2030
6.5.2 China Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharma Potency Assays Sales Value, 2019-2030
6.6.2 Japan Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharma Potency Assays Sales Value, 2019-2030
6.7.2 South Korea Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharma Potency Assays Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharma Potency Assays Sales Value, 2019-2030
6.9.2 India Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 ARL Bio Pharma
7.1.1 ARL Bio Pharma Profile
7.1.2 ARL Bio Pharma Main Business
7.1.3 ARL Bio Pharma Biopharma Potency Assays Products, Services and Solutions
7.1.4 ARL Bio Pharma Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.1.5 ARL Bio Pharma Recent Developments
7.2 BioPharm International
7.2.1 BioPharm International Profile
7.2.2 BioPharm International Main Business
7.2.3 BioPharm International Biopharma Potency Assays Products, Services and Solutions
7.2.4 BioPharm International Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.2.5 BioPharm International Recent Developments
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Profile
7.3.2 Charles River Laboratories Main Business
7.3.3 Charles River Laboratories Biopharma Potency Assays Products, Services and Solutions
7.3.4 Charles River Laboratories Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.3.5 DiscoverX Recent Developments
7.4 DiscoverX
7.4.1 DiscoverX Profile
7.4.2 DiscoverX Main Business
7.4.3 DiscoverX Biopharma Potency Assays Products, Services and Solutions
7.4.4 DiscoverX Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.4.5 DiscoverX Recent Developments
7.5 Eurofins Scientific
7.5.1 Eurofins Scientific Profile
7.5.2 Eurofins Scientific Main Business
7.5.3 Eurofins Scientific Biopharma Potency Assays Products, Services and Solutions
7.5.4 Eurofins Scientific Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.5.5 Eurofins Scientific Recent Developments
7.6 Intertek
7.6.1 Intertek Profile
7.6.2 Intertek Main Business
7.6.3 Intertek Biopharma Potency Assays Products, Services and Solutions
7.6.4 Intertek Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.6.5 Intertek Recent Developments
7.7 Kymos
7.7.1 Kymos Profile
7.7.2 Kymos Main Business
7.7.3 Kymos Biopharma Potency Assays Products, Services and Solutions
7.7.4 Kymos Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.7.5 Kymos Recent Developments
7.8 Pacific BioLabs
7.8.1 Pacific BioLabs Profile
7.8.2 Pacific BioLabs Main Business
7.8.3 Pacific BioLabs Biopharma Potency Assays Products, Services and Solutions
7.8.4 Pacific BioLabs Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.8.5 Pacific BioLabs Recent Developments
7.9 Pharmaron
7.9.1 Pharmaron Profile
7.9.2 Pharmaron Main Business
7.9.3 Pharmaron Biopharma Potency Assays Products, Services and Solutions
7.9.4 Pharmaron Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.9.5 Pharmaron Recent Developments
7.10 Promega
7.10.1 Promega Profile
7.10.2 Promega Main Business
7.10.3 Promega Biopharma Potency Assays Products, Services and Solutions
7.10.4 Promega Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.10.5 Promega Recent Developments
7.11 Sartorius
7.11.1 Sartorius Profile
7.11.2 Sartorius Main Business
7.11.3 Sartorius Biopharma Potency Assays Products, Services and Solutions
7.11.4 Sartorius Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.11.5 Sartorius Recent Developments
7.12 SGS
7.12.1 SGS Profile
7.12.2 SGS Main Business
7.12.3 SGS Biopharma Potency Assays Products, Services and Solutions
7.12.4 SGS Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.12.5 SGS Recent Developments
7.13 ViruSure
7.13.1 ViruSure Profile
7.13.2 ViruSure Main Business
7.13.3 ViruSure Biopharma Potency Assays Products, Services and Solutions
7.13.4 ViruSure Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.13.5 ViruSure Recent Developments
7.14 Zelle Biotechnology
7.14.1 Zelle Biotechnology Profile
7.14.2 Zelle Biotechnology Main Business
7.14.3 Zelle Biotechnology Biopharma Potency Assays Products, Services and Solutions
7.14.4 Zelle Biotechnology Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.14.5 Zelle Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Biopharma Potency Assays Industrial Chain
8.2 Biopharma Potency Assays Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharma Potency Assays Sales Model
8.5.2 Sales Channel
8.5.3 Biopharma Potency Assays Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Biopharma Potency Assays Product Introduction
1.2 Global Biopharma Potency Assays Market Size Forecast
1.3 Biopharma Potency Assays Market Trends & Drivers
1.3.1 Biopharma Potency Assays Industry Trends
1.3.2 Biopharma Potency Assays Market Drivers & Opportunity
1.3.3 Biopharma Potency Assays Market Challenges
1.3.4 Biopharma Potency Assays Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharma Potency Assays Players Revenue Ranking (2023)
2.2 Global Biopharma Potency Assays Revenue by Company (2019-2024)
2.3 Key Companies Biopharma Potency Assays Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharma Potency Assays Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharma Potency Assays
2.6 Biopharma Potency Assays Market Competitive Analysis
2.6.1 Biopharma Potency Assays Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharma Potency Assays Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Potency Assays as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Intracellular Potency Assay
3.1.2 Extracellular Potency Assay
3.2 Global Biopharma Potency Assays Sales Value by Type
3.2.1 Global Biopharma Potency Assays Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharma Potency Assays Sales Value, by Type (2019-2030)
3.2.3 Global Biopharma Potency Assays Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Cytology
4.1.3 Other
4.2 Global Biopharma Potency Assays Sales Value by Application
4.2.1 Global Biopharma Potency Assays Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharma Potency Assays Sales Value, by Application (2019-2030)
4.2.3 Global Biopharma Potency Assays Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharma Potency Assays Sales Value by Region
5.1.1 Global Biopharma Potency Assays Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharma Potency Assays Sales Value by Region (2019-2024)
5.1.3 Global Biopharma Potency Assays Sales Value by Region (2025-2030)
5.1.4 Global Biopharma Potency Assays Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharma Potency Assays Sales Value, 2019-2030
5.2.2 North America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharma Potency Assays Sales Value, 2019-2030
5.3.2 Europe Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharma Potency Assays Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharma Potency Assays Sales Value, 2019-2030
5.5.2 South America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharma Potency Assays Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharma Potency Assays Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharma Potency Assays Sales Value
6.3 United States
6.3.1 United States Biopharma Potency Assays Sales Value, 2019-2030
6.3.2 United States Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharma Potency Assays Sales Value, 2019-2030
6.4.2 Europe Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharma Potency Assays Sales Value, 2019-2030
6.5.2 China Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharma Potency Assays Sales Value, 2019-2030
6.6.2 Japan Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharma Potency Assays Sales Value, 2019-2030
6.7.2 South Korea Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharma Potency Assays Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharma Potency Assays Sales Value, 2019-2030
6.9.2 India Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharma Potency Assays Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 ARL Bio Pharma
7.1.1 ARL Bio Pharma Profile
7.1.2 ARL Bio Pharma Main Business
7.1.3 ARL Bio Pharma Biopharma Potency Assays Products, Services and Solutions
7.1.4 ARL Bio Pharma Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.1.5 ARL Bio Pharma Recent Developments
7.2 BioPharm International
7.2.1 BioPharm International Profile
7.2.2 BioPharm International Main Business
7.2.3 BioPharm International Biopharma Potency Assays Products, Services and Solutions
7.2.4 BioPharm International Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.2.5 BioPharm International Recent Developments
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Profile
7.3.2 Charles River Laboratories Main Business
7.3.3 Charles River Laboratories Biopharma Potency Assays Products, Services and Solutions
7.3.4 Charles River Laboratories Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.3.5 DiscoverX Recent Developments
7.4 DiscoverX
7.4.1 DiscoverX Profile
7.4.2 DiscoverX Main Business
7.4.3 DiscoverX Biopharma Potency Assays Products, Services and Solutions
7.4.4 DiscoverX Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.4.5 DiscoverX Recent Developments
7.5 Eurofins Scientific
7.5.1 Eurofins Scientific Profile
7.5.2 Eurofins Scientific Main Business
7.5.3 Eurofins Scientific Biopharma Potency Assays Products, Services and Solutions
7.5.4 Eurofins Scientific Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.5.5 Eurofins Scientific Recent Developments
7.6 Intertek
7.6.1 Intertek Profile
7.6.2 Intertek Main Business
7.6.3 Intertek Biopharma Potency Assays Products, Services and Solutions
7.6.4 Intertek Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.6.5 Intertek Recent Developments
7.7 Kymos
7.7.1 Kymos Profile
7.7.2 Kymos Main Business
7.7.3 Kymos Biopharma Potency Assays Products, Services and Solutions
7.7.4 Kymos Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.7.5 Kymos Recent Developments
7.8 Pacific BioLabs
7.8.1 Pacific BioLabs Profile
7.8.2 Pacific BioLabs Main Business
7.8.3 Pacific BioLabs Biopharma Potency Assays Products, Services and Solutions
7.8.4 Pacific BioLabs Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.8.5 Pacific BioLabs Recent Developments
7.9 Pharmaron
7.9.1 Pharmaron Profile
7.9.2 Pharmaron Main Business
7.9.3 Pharmaron Biopharma Potency Assays Products, Services and Solutions
7.9.4 Pharmaron Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.9.5 Pharmaron Recent Developments
7.10 Promega
7.10.1 Promega Profile
7.10.2 Promega Main Business
7.10.3 Promega Biopharma Potency Assays Products, Services and Solutions
7.10.4 Promega Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.10.5 Promega Recent Developments
7.11 Sartorius
7.11.1 Sartorius Profile
7.11.2 Sartorius Main Business
7.11.3 Sartorius Biopharma Potency Assays Products, Services and Solutions
7.11.4 Sartorius Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.11.5 Sartorius Recent Developments
7.12 SGS
7.12.1 SGS Profile
7.12.2 SGS Main Business
7.12.3 SGS Biopharma Potency Assays Products, Services and Solutions
7.12.4 SGS Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.12.5 SGS Recent Developments
7.13 ViruSure
7.13.1 ViruSure Profile
7.13.2 ViruSure Main Business
7.13.3 ViruSure Biopharma Potency Assays Products, Services and Solutions
7.13.4 ViruSure Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.13.5 ViruSure Recent Developments
7.14 Zelle Biotechnology
7.14.1 Zelle Biotechnology Profile
7.14.2 Zelle Biotechnology Main Business
7.14.3 Zelle Biotechnology Biopharma Potency Assays Products, Services and Solutions
7.14.4 Zelle Biotechnology Biopharma Potency Assays Revenue (US$ Million) & (2019-2024)
7.14.5 Zelle Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Biopharma Potency Assays Industrial Chain
8.2 Biopharma Potency Assays Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharma Potency Assays Sales Model
8.5.2 Sales Channel
8.5.3 Biopharma Potency Assays Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Biopharma Potency Assays Market Trends
Table 2. Biopharma Potency Assays Market Drivers & Opportunity
Table 3. Biopharma Potency Assays Market Challenges
Table 4. Biopharma Potency Assays Market Restraints
Table 5. Global Biopharma Potency Assays Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Biopharma Potency Assays Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Biopharma Potency Assays Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Biopharma Potency Assays Product Type
Table 9. Key Companies Time to Begin Mass Production of Biopharma Potency Assays
Table 10. Global Biopharma Potency Assays Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Potency Assays as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Biopharma Potency Assays Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Biopharma Potency Assays Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Biopharma Potency Assays Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Biopharma Potency Assays Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Biopharma Potency Assays Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Biopharma Potency Assays Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Biopharma Potency Assays Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Biopharma Potency Assays Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Biopharma Potency Assays Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Biopharma Potency Assays Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Biopharma Potency Assays Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Biopharma Potency Assays Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Biopharma Potency Assays Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Biopharma Potency Assays Sales Value by Region (2019-2024) & (%)
Table 27. Global Biopharma Potency Assays Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Biopharma Potency Assays Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Biopharma Potency Assays Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Biopharma Potency Assays Sales Value, (2025-2030) & (US$ Million)
Table 31. ARL Bio Pharma Basic Information List
Table 32. ARL Bio Pharma Description and Business Overview
Table 33. ARL Bio Pharma Biopharma Potency Assays Products, Services and Solutions
Table 34. Revenue (US$ Million) in Biopharma Potency Assays Business of ARL Bio Pharma (2019-2024)
Table 35. ARL Bio Pharma Recent Developments
Table 36. BioPharm International Basic Information List
Table 37. BioPharm International Description and Business Overview
Table 38. BioPharm International Biopharma Potency Assays Products, Services and Solutions
Table 39. Revenue (US$ Million) in Biopharma Potency Assays Business of BioPharm International (2019-2024)
Table 40. BioPharm International Recent Developments
Table 41. Charles River Laboratories Basic Information List
Table 42. Charles River Laboratories Description and Business Overview
Table 43. Charles River Laboratories Biopharma Potency Assays Products, Services and Solutions
Table 44. Revenue (US$ Million) in Biopharma Potency Assays Business of Charles River Laboratories (2019-2024)
Table 45. Charles River Laboratories Recent Developments
Table 46. DiscoverX Basic Information List
Table 47. DiscoverX Description and Business Overview
Table 48. DiscoverX Biopharma Potency Assays Products, Services and Solutions
Table 49. Revenue (US$ Million) in Biopharma Potency Assays Business of DiscoverX (2019-2024)
Table 50. DiscoverX Recent Developments
Table 51. Eurofins Scientific Basic Information List
Table 52. Eurofins Scientific Description and Business Overview
Table 53. Eurofins Scientific Biopharma Potency Assays Products, Services and Solutions
Table 54. Revenue (US$ Million) in Biopharma Potency Assays Business of Eurofins Scientific (2019-2024)
Table 55. Eurofins Scientific Recent Developments
Table 56. Intertek Basic Information List
Table 57. Intertek Description and Business Overview
Table 58. Intertek Biopharma Potency Assays Products, Services and Solutions
Table 59. Revenue (US$ Million) in Biopharma Potency Assays Business of Intertek (2019-2024)
Table 60. Intertek Recent Developments
Table 61. Kymos Basic Information List
Table 62. Kymos Description and Business Overview
Table 63. Kymos Biopharma Potency Assays Products, Services and Solutions
Table 64. Revenue (US$ Million) in Biopharma Potency Assays Business of Kymos (2019-2024)
Table 65. Kymos Recent Developments
Table 66. Pacific BioLabs Basic Information List
Table 67. Pacific BioLabs Description and Business Overview
Table 68. Pacific BioLabs Biopharma Potency Assays Products, Services and Solutions
Table 69. Revenue (US$ Million) in Biopharma Potency Assays Business of Pacific BioLabs (2019-2024)
Table 70. Pacific BioLabs Recent Developments
Table 71. Pharmaron Basic Information List
Table 72. Pharmaron Description and Business Overview
Table 73. Pharmaron Biopharma Potency Assays Products, Services and Solutions
Table 74. Revenue (US$ Million) in Biopharma Potency Assays Business of Pharmaron (2019-2024)
Table 75. Pharmaron Recent Developments
Table 76. Promega Basic Information List
Table 77. Promega Description and Business Overview
Table 78. Promega Biopharma Potency Assays Products, Services and Solutions
Table 79. Revenue (US$ Million) in Biopharma Potency Assays Business of Promega (2019-2024)
Table 80. Promega Recent Developments
Table 81. Sartorius Basic Information List
Table 82. Sartorius Description and Business Overview
Table 83. Sartorius Biopharma Potency Assays Products, Services and Solutions
Table 84. Revenue (US$ Million) in Biopharma Potency Assays Business of Sartorius (2019-2024)
Table 85. Sartorius Recent Developments
Table 86. SGS Basic Information List
Table 87. SGS Description and Business Overview
Table 88. SGS Biopharma Potency Assays Products, Services and Solutions
Table 89. Revenue (US$ Million) in Biopharma Potency Assays Business of SGS (2019-2024)
Table 90. SGS Recent Developments
Table 91. ViruSure Basic Information List
Table 92. ViruSure Description and Business Overview
Table 93. ViruSure Biopharma Potency Assays Products, Services and Solutions
Table 94. Revenue (US$ Million) in Biopharma Potency Assays Business of ViruSure (2019-2024)
Table 95. ViruSure Recent Developments
Table 96. Zelle Biotechnology Basic Information List
Table 97. Zelle Biotechnology Description and Business Overview
Table 98. Zelle Biotechnology Biopharma Potency Assays Products, Services and Solutions
Table 99. Revenue (US$ Million) in Biopharma Potency Assays Business of Zelle Biotechnology (2019-2024)
Table 100. Zelle Biotechnology Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Biopharma Potency Assays Downstream Customers
Table 104. Biopharma Potency Assays Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Biopharma Potency Assays Product Picture
Figure 2. Global Biopharma Potency Assays Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 4. Biopharma Potency Assays Report Years Considered
Figure 5. Global Biopharma Potency Assays Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharma Potency Assays Revenue in 2023
Figure 7. Biopharma Potency Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Intracellular Potency Assay Picture
Figure 9. Extracellular Potency Assay Picture
Figure 10. Global Biopharma Potency Assays Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Biopharma Potency Assays Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Pharmaceutical
Figure 13. Product Picture of Cytology
Figure 14. Product Picture of Other
Figure 15. Global Biopharma Potency Assays Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Biopharma Potency Assays Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Biopharma Potency Assays Sales Value (%), (2019-2030)
Figure 28. United States Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 34. China Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 36. China Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 46. India Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 48. India Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 49. Biopharma Potency Assays Industrial Chain
Figure 50. Biopharma Potency Assays Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Table 1. Biopharma Potency Assays Market Trends
Table 2. Biopharma Potency Assays Market Drivers & Opportunity
Table 3. Biopharma Potency Assays Market Challenges
Table 4. Biopharma Potency Assays Market Restraints
Table 5. Global Biopharma Potency Assays Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Biopharma Potency Assays Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Biopharma Potency Assays Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Biopharma Potency Assays Product Type
Table 9. Key Companies Time to Begin Mass Production of Biopharma Potency Assays
Table 10. Global Biopharma Potency Assays Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Potency Assays as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Biopharma Potency Assays Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Biopharma Potency Assays Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Biopharma Potency Assays Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Biopharma Potency Assays Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Biopharma Potency Assays Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Biopharma Potency Assays Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Biopharma Potency Assays Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Biopharma Potency Assays Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Biopharma Potency Assays Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Biopharma Potency Assays Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Biopharma Potency Assays Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Biopharma Potency Assays Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Biopharma Potency Assays Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Biopharma Potency Assays Sales Value by Region (2019-2024) & (%)
Table 27. Global Biopharma Potency Assays Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Biopharma Potency Assays Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Biopharma Potency Assays Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Biopharma Potency Assays Sales Value, (2025-2030) & (US$ Million)
Table 31. ARL Bio Pharma Basic Information List
Table 32. ARL Bio Pharma Description and Business Overview
Table 33. ARL Bio Pharma Biopharma Potency Assays Products, Services and Solutions
Table 34. Revenue (US$ Million) in Biopharma Potency Assays Business of ARL Bio Pharma (2019-2024)
Table 35. ARL Bio Pharma Recent Developments
Table 36. BioPharm International Basic Information List
Table 37. BioPharm International Description and Business Overview
Table 38. BioPharm International Biopharma Potency Assays Products, Services and Solutions
Table 39. Revenue (US$ Million) in Biopharma Potency Assays Business of BioPharm International (2019-2024)
Table 40. BioPharm International Recent Developments
Table 41. Charles River Laboratories Basic Information List
Table 42. Charles River Laboratories Description and Business Overview
Table 43. Charles River Laboratories Biopharma Potency Assays Products, Services and Solutions
Table 44. Revenue (US$ Million) in Biopharma Potency Assays Business of Charles River Laboratories (2019-2024)
Table 45. Charles River Laboratories Recent Developments
Table 46. DiscoverX Basic Information List
Table 47. DiscoverX Description and Business Overview
Table 48. DiscoverX Biopharma Potency Assays Products, Services and Solutions
Table 49. Revenue (US$ Million) in Biopharma Potency Assays Business of DiscoverX (2019-2024)
Table 50. DiscoverX Recent Developments
Table 51. Eurofins Scientific Basic Information List
Table 52. Eurofins Scientific Description and Business Overview
Table 53. Eurofins Scientific Biopharma Potency Assays Products, Services and Solutions
Table 54. Revenue (US$ Million) in Biopharma Potency Assays Business of Eurofins Scientific (2019-2024)
Table 55. Eurofins Scientific Recent Developments
Table 56. Intertek Basic Information List
Table 57. Intertek Description and Business Overview
Table 58. Intertek Biopharma Potency Assays Products, Services and Solutions
Table 59. Revenue (US$ Million) in Biopharma Potency Assays Business of Intertek (2019-2024)
Table 60. Intertek Recent Developments
Table 61. Kymos Basic Information List
Table 62. Kymos Description and Business Overview
Table 63. Kymos Biopharma Potency Assays Products, Services and Solutions
Table 64. Revenue (US$ Million) in Biopharma Potency Assays Business of Kymos (2019-2024)
Table 65. Kymos Recent Developments
Table 66. Pacific BioLabs Basic Information List
Table 67. Pacific BioLabs Description and Business Overview
Table 68. Pacific BioLabs Biopharma Potency Assays Products, Services and Solutions
Table 69. Revenue (US$ Million) in Biopharma Potency Assays Business of Pacific BioLabs (2019-2024)
Table 70. Pacific BioLabs Recent Developments
Table 71. Pharmaron Basic Information List
Table 72. Pharmaron Description and Business Overview
Table 73. Pharmaron Biopharma Potency Assays Products, Services and Solutions
Table 74. Revenue (US$ Million) in Biopharma Potency Assays Business of Pharmaron (2019-2024)
Table 75. Pharmaron Recent Developments
Table 76. Promega Basic Information List
Table 77. Promega Description and Business Overview
Table 78. Promega Biopharma Potency Assays Products, Services and Solutions
Table 79. Revenue (US$ Million) in Biopharma Potency Assays Business of Promega (2019-2024)
Table 80. Promega Recent Developments
Table 81. Sartorius Basic Information List
Table 82. Sartorius Description and Business Overview
Table 83. Sartorius Biopharma Potency Assays Products, Services and Solutions
Table 84. Revenue (US$ Million) in Biopharma Potency Assays Business of Sartorius (2019-2024)
Table 85. Sartorius Recent Developments
Table 86. SGS Basic Information List
Table 87. SGS Description and Business Overview
Table 88. SGS Biopharma Potency Assays Products, Services and Solutions
Table 89. Revenue (US$ Million) in Biopharma Potency Assays Business of SGS (2019-2024)
Table 90. SGS Recent Developments
Table 91. ViruSure Basic Information List
Table 92. ViruSure Description and Business Overview
Table 93. ViruSure Biopharma Potency Assays Products, Services and Solutions
Table 94. Revenue (US$ Million) in Biopharma Potency Assays Business of ViruSure (2019-2024)
Table 95. ViruSure Recent Developments
Table 96. Zelle Biotechnology Basic Information List
Table 97. Zelle Biotechnology Description and Business Overview
Table 98. Zelle Biotechnology Biopharma Potency Assays Products, Services and Solutions
Table 99. Revenue (US$ Million) in Biopharma Potency Assays Business of Zelle Biotechnology (2019-2024)
Table 100. Zelle Biotechnology Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Biopharma Potency Assays Downstream Customers
Table 104. Biopharma Potency Assays Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Biopharma Potency Assays Product Picture
Figure 2. Global Biopharma Potency Assays Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 4. Biopharma Potency Assays Report Years Considered
Figure 5. Global Biopharma Potency Assays Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharma Potency Assays Revenue in 2023
Figure 7. Biopharma Potency Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Intracellular Potency Assay Picture
Figure 9. Extracellular Potency Assay Picture
Figure 10. Global Biopharma Potency Assays Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Biopharma Potency Assays Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Pharmaceutical
Figure 13. Product Picture of Cytology
Figure 14. Product Picture of Other
Figure 15. Global Biopharma Potency Assays Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Biopharma Potency Assays Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Biopharma Potency Assays Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Biopharma Potency Assays Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Biopharma Potency Assays Sales Value (%), (2019-2030)
Figure 28. United States Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 34. China Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 36. China Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 46. India Biopharma Potency Assays Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Biopharma Potency Assays Sales Value by Type (%), 2023 VS 2030
Figure 48. India Biopharma Potency Assays Sales Value by Application (%), 2023 VS 2030
Figure 49. Biopharma Potency Assays Industrial Chain
Figure 50. Biopharma Potency Assays Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Vibrating Viscometer Market Insights, Forecast to 2030
Dec 16, 24
Global Specialty Hoses Market Insights, Forecast to 2030
Dec 16, 24
Global Recreational Fiberglass Boat Market Insights, Forecast to 2030
Dec 16, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232